MILDRED KINNARD: Open Payments
NPI 1295044626 · NEWARK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$706 in 42 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $87 · 2025 $706
Food & beverage: $706
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $254 |
| Novo Nordisk Inc | 6 | $108 |
| Astellas Pharma US Inc | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Abbott Laboratories | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Merck Sharp & Dohme LLC | 2 | $28 |
| PFIZER INC. | 2 | $28 |
| Exact Sciences Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
Products named: VRAYLAR, QULIPTA, Veozah, Ozempic, UBRELVY, FREESTYLE LIBRE 3, FARXIGA, Rybelsus.
Industry payments across OH — which companies pay providers there.
